Orchestra BioMed Holdings, Inc.
OBIO
$4.86
-$0.13-2.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.82M | 2.94M | 2.89M | 2.64M | 2.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.82M | 2.94M | 2.89M | 2.64M | 2.65M |
| Cost of Revenue | 197.00K | 216.00K | 214.00K | 204.00K | 193.00K |
| Gross Profit | 2.62M | 2.73M | 2.67M | 2.43M | 2.45M |
| SG&A Expenses | 25.53M | 24.09M | 24.30M | 23.93M | 22.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 78.06M | 74.21M | 71.69M | 66.94M | 62.75M |
| Operating Income | -75.24M | -71.27M | -68.80M | -64.30M | -60.11M |
| Income Before Tax | -75.10M | -69.70M | -66.32M | -61.02M | -57.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -75.10 | -69.70 | -66.32 | -61.02 | -57.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -75.10M | -69.70M | -66.32M | -61.02M | -57.69M |
| EBIT | -75.24M | -71.27M | -68.80M | -64.30M | -60.11M |
| EBITDA | -74.91M | -70.94M | -68.48M | -63.99M | -59.81M |
| EPS Basic | -1.82 | -1.83 | -1.77 | -1.66 | -1.60 |
| Normalized Basic EPS | -1.14 | -1.14 | -1.11 | -1.03 | -0.97 |
| EPS Diluted | -1.82 | -1.83 | -1.77 | -1.66 | -1.60 |
| Normalized Diluted EPS | -1.14 | -1.14 | -1.11 | -1.03 | -0.97 |
| Average Basic Shares Outstanding | 166.88M | 152.31M | 149.72M | 147.26M | 144.34M |
| Average Diluted Shares Outstanding | 166.88M | 152.31M | 149.72M | 147.26M | 144.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |